Amryt Pharma (AMYT)

Sector:

Financials

Index:

FTSE AIM All-Share

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

13.75p
   
  • Change Today:
    -0.15p
  • 52 Week High: 19.38
  • 52 Week Low: 12.50
  • Currency: UK Pounds
  • Shares Issued: 274.82m
  • Volume: 77,500
  • Market Cap: 37.79m

Amryt Pharma Overview

Amryt Pharma is in the financials sector and is currently trading at 13.75p per share. In the last year Amryt Pharma's share price has ranged from 12.50p to 19.38p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart (19-03-2019)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -111.2% -151.3%
ROCE 171.8%  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 3.5 2.7
Pr/Book 2.0  
Latest F'cast
Revenue 846.7% -4.9%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Amryt Pharma Fundamentals

Year Ending Revenue ( m) Pre-tax ( m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-14 n/a (2.56) (0.87)¢ n/a n/a n/a n/a 0.0%
31-Mar-15 n/a (1.87) (4.32)¢ n/a n/a n/a n/a 0.0%
31-Dec-15 n/a (1.19) (2.84)¢ n/a n/a n/a n/a 0.0%
31-Dec-16 1.35 (7.80) (4.78)¢ n/a n/a n/a n/a 0.0%
31-Dec-17 12.78 (26.14) (11.72)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Amryt Pharma Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 14.20 (21.48) (8.42)p n/a n/a n/a n/a 0.0%
31-Dec-19 17.98 (28.82) (9.95)p n/a n/a n/a n/a 0.0%
31-Dec-20 20.96 (30.74) (12.26)p n/a n/a n/a n/a 0.0%

Copyright © 2019 FactSet Research Systems Inc. All rights reserved.

Amryt Pharma Company Announcements

Update on AP101 EASE Phase III trial 28-Feb-2019 07:00 RNS
Positive results for gene therapy AP103 07-Jan-2019 07:00 RNS
EASE Phase III trial interim efficacy results 04-Jan-2019 12:56 RNS

Latest Amryt Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Amryt Pharma Market Data

Currency UK Pounds
Share Price 13.75p
Change Today -0.15p
% Change -1.08 %
52 Week High 19.38
52 Week Low 12.50
Volume 77,500
Shares Issued 274.82m
Market Cap 37.79m

Amryt Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
22.57% below the market average22.57% below the market average22.57% below the market average22.57% below the market average22.57% below the market average
18.84% below the sector average18.84% below the sector average18.84% below the sector average18.84% below the sector average18.84% below the sector average
Price Trend
59.15% below the market average59.15% below the market average59.15% below the market average59.15% below the market average59.15% below the market average
43.23% below the sector average43.23% below the sector average43.23% below the sector average43.23% below the sector average43.23% below the sector average
Income Not Available
Growth
23.06% above the market average23.06% above the market average23.06% above the market average23.06% above the market average23.06% above the market average
28.46% above the sector average28.46% above the sector average28.46% above the sector average28.46% above the sector average28.46% above the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Amryt Pharma Dividends

No dividends found

Trades for 19-Mar-2019

Time Volume / Share Price
16:27 1,000 @ 13.50p
16:05 10,000 @ 13.60p
15:03 10,000 @ 13.56p
14:30 16,500 @ 13.75p
11:56 15,000 @ 13.70p

Amryt Pharma Key Personnel

CEO Joe Wiley
CFO Rory Nealon

Top of Page